MAZE · CIK 0001842295 · operating
Maze Therapeutics, Inc. (MAZE) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $2.2 billion, Maze Therapeutics, Inc. is a mid-cap company. The stock currently trades at $45.61, up 0.04% today, with a 52-week range of $6.71–$49.25.
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-31 | 0000950170-25-047208 | SEC ↗ |